Literature DB >> 31746604

Design, Synthesis, and Study of Lactam and Ring-Expanded Analogues of Teixobactin.

Hyunjun Yang1, Arthur V Pishenko1, Xingyue Li1, James S Nowick1.   

Abstract

This paper describes the chemical synthesis, X-ray crystallographic structure, and antibiotic activity assay of lactam analogues of teixobactin and explores ring-expanded analogues of teixobactin with β3-homo amino acids. Lactam analogues of teixobactin containing all four stereoisomers of aza-threonine at position 8 were synthesized on a solid support from commercially available stereoisomeric threonine derivatives. The threonine stereoisomers are converted to the diastereomeric aza-threonines by mesylation, azide displacement, and reduction during the synthesis. d-Aza-Thr8,Arg10-teixobactin exhibits 2-8-fold greater antibiotic activity than the corresponding macrolactone Arg10-teixobactin. Azateixobactin analogues containing other stereoisomers of aza-threonine are inactive. A dramatic 16-128-fold increase in the activity of teixobactin and teixobactin analogues is observed with the inclusion of 0.002% of the mild detergent polysorbate 80 in the MIC assay. The X-ray crystallographic structure of N-Me-d-Gln4,d-aza-Thr8,Arg10-teixobactin reveals an amphipathic hydrogen-bonded antiparallel β-sheet dimer that binds chloride anions. In the binding site, the macrolactam amide NH groups of residues 8, 10, and 11, as well as the extra amide NH group of the lactam ring, hydrogen bond to the chloride anion. The teixobactin pharmacophore tolerates ring expansion of the 13-membered ring to 14-,15-, and 16-membered rings containing β3-homo amino acids with retention of partial or full antibiotic activity.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31746604      PMCID: PMC7814697          DOI: 10.1021/acs.joc.9b02631

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  27 in total

1.  Substructure search procedures for macromolecular structures.

Authors:  R W Grosse-Kunstleve; P D Adams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2003-10-23

2.  electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation.

Authors:  Nigel W Moriarty; Ralf W Grosse-Kunstleve; Paul D Adams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-09-16

3.  Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.

Authors:  Jian Xie; Akinori Okano; Joshua G Pierce; Robert C James; Simon Stamm; Christine M Crane; Dale L Boger
Journal:  J Am Chem Soc       Date:  2012-01-06       Impact factor: 15.419

4.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

5.  A-16686, a new antibiotic from Actinoplanes. I. Fermentation, isolation and preliminary physico-chemical characteristics.

Authors:  B Cavalleri; H Pagani; G Volpe; E Selva; F Parenti
Journal:  J Antibiot (Tokyo)       Date:  1984-04       Impact factor: 2.649

6.  The structures of katanosins A and B.

Authors:  T Kato; H Hinoo; Y Terui; J Kikuchi; J Shoji
Journal:  J Antibiot (Tokyo)       Date:  1988-06       Impact factor: 2.649

7.  Lysobactin, a novel antibacterial agent produced by Lysobacter sp. II. Biological properties.

Authors:  D P Bonner; J O'Sullivan; S K Tanaka; J M Clark; R R Whitney
Journal:  J Antibiot (Tokyo)       Date:  1988-12       Impact factor: 2.649

8.  Alanine scan reveals modifiable residues in teixobactin.

Authors:  K H Chen; S P Le; X Han; J M Frias; J S Nowick
Journal:  Chem Commun (Camb)       Date:  2017-10-12       Impact factor: 6.222

9.  Teixobactin analogues reveal enduracididine to be non-essential for highly potent antibacterial activity and lipid II binding.

Authors:  Anish Parmar; Abhishek Iyer; Stephen H Prior; Daniel G Lloyd; Eunice Tze Leng Goh; Charlotte S Vincent; Timea Palmai-Pallag; Csanad Z Bachrati; Eefjan Breukink; Annemieke Madder; Rajamani Lakshminarayanan; Edward J Taylor; Ishwar Singh
Journal:  Chem Sci       Date:  2017-10-05       Impact factor: 9.825

10.  Decision-making in structure solution using Bayesian estimates of map quality: the PHENIX AutoSol wizard.

Authors:  Thomas C Terwilliger; Paul D Adams; Randy J Read; Airlie J McCoy; Nigel W Moriarty; Ralf W Grosse-Kunstleve; Pavel V Afonine; Peter H Zwart; Li Wei Hung
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-05-15
View more
  3 in total

1.  Visualizing the mode of action and supramolecular assembly of teixobactin analogues in Bacillus subtilis.

Authors:  Michael A Morris; Alexander Vallmitjana; Fabian Grein; Tanja Schneider; Melina Arts; Chelsea R Jones; Betty T Nguyen; Mohammad H Hashemian; Melody Malek; Enrico Gratton; James S Nowick
Journal:  Chem Sci       Date:  2022-05-13       Impact factor: 9.969

2.  Teixobactin kills bacteria by a two-pronged attack on the cell envelope.

Authors:  Rhythm Shukla; Francesca Lavore; Sourav Maity; Maik G N Derks; Chelsea R Jones; Bram J A Vermeulen; Adéla Melcrová; Michael A Morris; Lea Marie Becker; Xiaoqi Wang; Raj Kumar; João Medeiros-Silva; Roy A M van Beekveld; Alexandre M J J Bonvin; Joseph H Lorent; Moreno Lelli; James S Nowick; Harold D MacGillavry; Aaron J Peoples; Amy L Spoering; Losee L Ling; Dallas E Hughes; Wouter H Roos; Eefjan Breukink; Kim Lewis; Markus Weingarth
Journal:  Nature       Date:  2022-08-03       Impact factor: 69.504

Review 3.  Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides-A Review.

Authors:  András Fodor; Birhan Addisie Abate; Péter Deák; László Fodor; Ervin Gyenge; Michael G Klein; Zsuzsanna Koncz; Josephat Muvevi; László Ötvös; Gyöngyi Székely; Dávid Vozik; László Makrai
Journal:  Pathogens       Date:  2020-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.